ArticleAbdominal radiology (New York)2026
Preoperative prediction of cervical cancer recurrence using explainable MRI radiomics: a SHAP-Guided machine learning study.
Article in Abdominal radiology (New York), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
purposeTo develop and validate a machine learning model that integrated MRI radiomics features and clinical factors for preoperative prediction of postoperative recurrence in cervical cancer.
methodsThis retrospective study included 268 patients with pathologically confirmed cervical cancer (training cohort: n = 185; validation cohort: n = 83). A total of 124 radiomics features were extracted from T2-weighted images, with 12 optimal features were selected through reproducibility analysis (ICC > 0.75), minimum redundancy maximum relevance (mRMR), and least absolute shrinkage and selection operator (LASSO) regression. Four machine learning (ML) models (logistic regression [LR], naïve Bayes [NB], gradient boosting machine [GBM], random forest [RF]) were trained and evaluated for their discrimination performance (area under the curve [AUC], sensitivity, specificity), calibration accuracy, and clinical utility (via decision curve analysis [DCA]). SHapley Additive exPlanations (SHAP) were employed to elucidate the importance of each feature.
resultsThe LR model demonstrated the highest performance in the validation cohort (AUC = 0.818, sensitivity = 0.629, specificity = 0.806), which significantly outperformed clinical factors alone (AUC = 0.681, P = 0.005). SHAP analysis identified tumor heterogeneity features such as original_firstorder_Minimum and GLCM-correlation, as the top predictors. The combined radiomics-clinical model further improved AUC to 0.844. DCA confirmed a net benefit across clinically relevant risk thresholds.
conclusionAn interpretable ML radiomics model that leveraged preoperative MRI and clinical data showed potential to stratify the risk of recurrence in cervical cancer, thereby offering potential to guide personalized decisions regarding surgical and adjuvant therapies.
Indexed as
Identifiers
41207886What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.